NeoGenomics, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
NeoGenomics, Inc. (NEO) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $18.65 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2018-03-13
- NeoGenomics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2017 was $18.65M, a 539.51% increase from fiscal 2016.
- NeoGenomics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2016 was $2.92M, a 67.68% increase from fiscal 2015.
- NeoGenomics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2015 was $1.74M, a 37.83% decline from fiscal 2014.
- NeoGenomics, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2014 was $2.80M, a 122.16% increase from fiscal 2013.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|
| 2017-12-31 | $18.65M 10-K · filed 2018-03-13 |
| 2016-12-31 | $2.92M 10-K · filed 2018-03-13 |
| 2015-12-31 | $1.74M 10-K · filed 2018-03-13 |
| 2014-12-31 | $2.80M 10-K · filed 2017-03-14 |
| 2013-12-31 | $1.26M 10-K · filed 2016-04-18 |
| 2012-12-31 | $2.20M 10-K · filed 2015-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |